NACCO Stock Hits New 52-Week Low (NC)

NEW YORK ( TheStreet) -- NACCO Industries (NYSE: NC) hit a new 52-week low Monday as it is currently trading at $66.46, below its previous 52-week low of $66.68 with 16,362 shares traded as of 2:19 p.m. ET. Average volume has been 36,000 shares over the past 30 days.

NACCO has a market cap of $483.8 million and is part of the industrial goods sector and industrial industry. Shares are down 36.4% year to date as of the close of trading on Friday.

NACCO Industries, Inc., through its subsidiaries, operates in lift trucks, small appliances, specialty retail, and mining industries in the Americas, Europe, the Middle East, Africa, and the Asia-Pacific. The company has a P/E ratio of 4.5, equal to the average industrial industry P/E ratio and below the S&P 500 P/E ratio of 17.7.
  • Practice your NC trading strategies and win cash in our stock game.

TheStreet Ratings rates NACCO as a hold. The company's strengths can be seen in multiple areas, such as its robust revenue growth, largely solid financial position with reasonable debt levels by most measures and notable return on equity. However, as a counter to these strengths, we also find weaknesses including poor profit margins and a generally disappointing performance in the stock itself. You can view the full NACCO Ratings Report.

See all 52-week low stocks or get investment ideas from our investment research center.

null

More from Markets

Don't Panic! The Risk of a Recession This Year Is Low

Don't Panic! The Risk of a Recession This Year Is Low

Even Standing Desk Company Varidesk Is Watching How the Trump Tariffs Play Out

Even Standing Desk Company Varidesk Is Watching How the Trump Tariffs Play Out

State Street Gets Pummeled on Software Deal; Pizza Wars Are Raging -- ICYMI

State Street Gets Pummeled on Software Deal; Pizza Wars Are Raging -- ICYMI

Schlumberger Stock Dips as Investors Ignore Start of 'Earnings Liftoff'

Schlumberger Stock Dips as Investors Ignore Start of 'Earnings Liftoff'

GSK Shares Climb as Board Is Said to Mull Breakup of Pharma Giant

GSK Shares Climb as Board Is Said to Mull Breakup of Pharma Giant